1. Home
  2. AGBK vs DRTS Comparison

AGBK vs DRTS Comparison

Compare AGBK & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGBK

AGI Inc Class A Common Shares

N/A

Current Price

$6.45

Market Cap

1.0B

Sector

Finance

ML Signal

N/A

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$9.31

Market Cap

978.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGBK
DRTS
Founded
1999
2015
Country
Brazil
Israel
Employees
5001
121
Industry
Commercial Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
978.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AGBK
DRTS
Price
$6.45
$9.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$17.20
$8.67
AVG Volume (30 Days)
414.7K
1.1M
Earning Date
05-05-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$235.22
$699.98
P/E Ratio
$46.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.32
$2.87
52 Week High
$12.21
$11.62

Technical Indicators

Market Signals
Indicator
AGBK
DRTS
Relative Strength Index (RSI) 38.86 48.44
Support Level $6.43 $6.59
Resistance Level $7.65 $11.62
Average True Range (ATR) 0.36 0.95
MACD -0.05 -0.21
Stochastic Oscillator 12.15 20.88

Price Performance

Historical Comparison
AGBK
DRTS

About AGBK AGI Inc Class A Common Shares

AGI Inc is a technology-powered provider of specialized financial services in Brazil. It empowers clients to access their social security benefits, severance fund benefits, and public or private sector payrolls through secured lending solutions and complementary banking, credit and insurance products tailored as per client needs. The company has one operating segment related to the banking business. The Bank provides a standardized set of financial products and services exclusively to individuals, mainly focused on credit, including digital accounts, cards, payroll and personal loans, and insurance offered through partners.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: